Pluristem Therapeutics Stock Price (NASDAQ:PSTI)

Add to My Stocks
$1.2 $0.02 (1.69%) PSTI stock closing price Jul 21, 2017 (Closing)
Prev Close* : $1.18
Market Cap:
Day Low: $1.19
52 Week Low: $1.04
Open: $1.19
Volume: 141470
Day High: $1.25
52 Week High: $1.85

Latest Stock Market News

Latest Articles

Pluristem Therapeutics News - From Partners

Pluristem Announces Bought Deal Offering   by Globe Newswire on Jan 19, 2017

PSTI Stockcharts

View PSTI PE ratio, PS ratio stocks charts and compare with peers.
PSTI Chart
Note: Compare Pluristem Therapeutics stock price history with the index and industry peers.

PSTI Industry Peers

Company Price Change (%)
Proteostasis (PTI)3.510.14 (3.84%)
Cidara Therapeutics (CDTX)80 (0%)
United Therapeutics (UTHR)129.981.38 (1.05%)
Athersys (ATHX)1.640.01 (0.61%)
Steadymed (STDY)6.50.05 (0.78%)
Mesoblast (MESO)7.710.04 (0.52%)
Capricor Therapeutics (CAPR)1.310.04 (3.15%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Mirati Therapeutics (MRTX)4.90.25 (5.38%)
Cytokinetics (CYTK)14.50.65 (4.69%)
Fortress Biotech (FBIO)4.870.2 (4.28%)
Revance (RVNC)23.750.95 (4.17%)
BioDelivery Sciences (BDSI)3.250.1 (3.17%)
Compugen (CGEN)3.550.1 (2.9%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Peregrine Pharma (PPHM)4.60.62 (11.88%)
Alimera Sciences (ALIM)1.450.13 (8.23%)
Trevena (TRVN)2.7550.22 (7.41%)
Vital Therapies (VTL)2.650.15 (5.36%)
ALBIREO PHARMA (ALBO)26.211.41 (5.1%)
Achillion Pharma (ACHN)4.110.21 (4.86%)
MannKind (MNKD)1.30.06 (4.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017

Pluristem Therapeutics Inc. Stock News - Partner Headlines

GuruFocus insider data   on Sep 27, 2015

Pluristem Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues2.84M0.37M0.37M0.67M0.71M
Net Income-23.24M-24.67M-26.93M-21.15M-14.79M
Total Operating Expense26.06M25.63M28.21M22.87M15.73M
view Pluristem Therapeutics Inc. income statement
balance sheet20162015201420132012
Total Assets45.94M68.15M74.02M68.31M47.42M
Total Liabilities7.78M10.01M11.9M10.85M9.67M
Shareholders Equity38.15M58.14M62.12M57.46M37.74M
view Pluristem Therapeutics Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.92M-2.63M-0.59M0.33M6.1M
Net Cash From (Used By) Operating Activities-18.52M-20.6M-19.12M-16.88M-3.27M
Increase (Decrease) In Prop Plant And Equipment-1.72M-0.81M-1.57M-4.3M-1.48M
view Pluristem Therapeutics Inc. cashflow statement

Pluristem Therapeutics Stock Message Board

An investor needs to spend 1.2 to buy PSTI stock, as the closing Pluristem Therapeutics stock price is 1.2. Pluristem Therapeutics market capitalization is 113.67M and it represents the total market value of PSTI stock. Pluristem Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Pluristem Therapeutics stock price and Pluristem Therapeutics share price mean the same thing. 141470 PSTI shares were traded yesterday, and Pluristem Therapeutics stock chart shows that the PSTI stock quote hit a day high of 1.25 and day low of 1.19. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Pluristem Therapeutics stock price history.